(URIROX-2) Establishing the Safety and Efficacy of Reloxaliase (Oxalate Decarboxylase) in Patients with Enteric Hyperoxaluria

The PI of this project is:

This project is funded by: Allena Pharmaceuticals, Inc.

The term of this project is: April 2019 to May 2025

The number of subjects scanned during this project is: 5